INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) traded up 3.2% during mid-day trading on Thursday . The company traded as high as $0.84 and last traded at $0.81. 25,352 shares were traded during trading, a decline of 98% from the average session volume of 1,587,563 shares. The stock had previously closed at $0.79.
INVO Bioscience Trading Up 3.2 %
The stock’s fifty day moving average is $0.84 and its 200-day moving average is $0.82.
Hedge Funds Weigh In On INVO Bioscience
An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. acquired a new stake in INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned 2.64% of INVO Bioscience at the end of the most recent quarter. Institutional investors own 12.02% of the company’s stock.
About INVO Bioscience
INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Read More
- Five stocks we like better than INVO Bioscience
- Comparing and Trading High PE Ratio Stocks
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- Investing in the High PE Growth Stocks
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What is an Earnings Surprise?
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.